UPPSALA, SWEDEN / ACCESS Newswire / March 5, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - The Board of Directors of Biovica International AB today announces that Chief Executiv ...

KOMZIFTI™ (ziftomenib) launch generating early revenue momentum and rapid payer coverage decisions – – Market feedback emphasizes differentiated safety, combinability and convenience of ziftomenib, su ...

UroGen Pharma's ZUSDURI is positioned for accelerated adoption following a permanent J-Code in 2026. Read more on URGN stock and why it is a Buy.

An artificial intelligence (AI) algorithm used to detect breast cancer in screening scans has been adapted into a risk score ...

Can-Fite BioPharma (CANF) stock jumped 107% after namodenoson successfully completed Phase 2a safety testing in 20 pancreatic cancer patients.

Gene Solutions announced its strategic entry into the Turkish market at the 2nd International Hereditary Cancers Congress ...

Endometrial cancer (EC) incidence is rising globally, yet therapeutic progress has lagged behind other solid tumors, in part due to the complexity and ...

Floodlight reports Louisiana is investing in "blue ammonia," raising concerns among locals about health risks from proposed ...

Agreement provides additional funding tool of up to $25 million over a period of up to 36 months - Underpins the Company's ambitions to expand its commercialisation activities and advance its innovati ...

Arvinas (NASDAQ:ARVN) continues to gain attention in Nasdaq Futures, advancing in targeted protein degradation therapies for ...

King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a pioneering high-intensity focused ultrasound (HIFU) treatment for prostate cancer for the first time ...

New fasting feature offers beginner to advanced fasting plans, real-time tracking, fasting stage education, and ...